Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12404 |
CCK-A receptor inhibitor 1
|
cholecystokinin | GPCR/G Protein |
CCK-A receptor inhibitor 1 是一种有效的缩胆囊素 A (CCK-A) 受体抑制剂(IC50:340 nM)。CCK-A receptor inhibitor 1 可用于研究与消化系统相关的疾病。 | |||
T1052 |
Proglumide
二丙谷酰胺 |
cholecystokinin | GPCR/G Protein |
Proglumide (Binoside) 是一种非肽的、口服具有活性的胆囊收缩素(CCK)-A/B 受体拮抗剂。它能够选择性阻断 CCK 在中枢神经系统中的作用。它能够抑制胃分泌,具有保护胃十二指肠粘膜的能力,并表现出抗癫痫和抗氧化活性。 | |||
T13260 |
Gastrin/CCK antagonist 1
|
cholecystokinin | GPCR/G Protein |
Gastrin/CCK antagonist 1 是一种有效的 gastrin/CCK 拮抗剂,可用于研究代谢系统相关疾病。 | |||
TP2204L |
CCK Octapeptide, non-sulfated acetate
CCK Octapeptide, non-sulfated acetate(25679-24-7 Free base) |
cholecystokinin | GPCR/G Protein |
CCK Octapeptide, non-sulfated acetate 是一种合成的胆囊收缩素脱硫酸肽。 | |||
TP2419 |
V-9-M Cholecystokinin nonapeptide
V 9 M,Prepro CCK Fragment V-9-M,Val-pro-val-glu-ala-val-asp-pro-met,Cholecystokinin Precursor (24-32),V9M,V-9-M |
Beta Amyloid | Neuroscience |
V-9-M Cholecystokinin nonapeptide (Prepro CCK Fragment V-9-M) 是胆囊收缩素(CCK)的前体化合物。胆囊收缩素(CCK)是一种刺激胆囊收缩和胰腺外分泌的脑肠肽,可从狗和猫的小肠中提取的,可以引起胆囊收缩。 | |||
T9343 |
N-Cbz-DL-tryptophan
|
cholecystokinin | GPCR/G Protein |
N-Cbz-DL-tryptophan 是一种胆囊收缩素受体拮抗剂,可消除离体心脏对 CCK-8 的反应。 | |||
T9991 |
WAY-620645
|
cholecystokinin | GPCR/G Protein |
WAY-620645 是一种 CCK 拮抗剂,具有抗肿瘤和镇痛活性。 | |||
TP1198 |
Sincalide ammonium
SQ19844 ammonium,CCK-8 ammonium,Cholecystokinin octapeptide ammonium |
cholecystokinin | GPCR/G Protein |
Sincalide ammonium (CCK-8 ammonium) 是一种有效的氨基酸多肽激素胆囊收缩素 (CCK) 的类似物,是保留了 CCK 的大部分生物活性的活性片段。Sincalide ammonium 促进胆汁的分泌,使胆囊收缩并使 Oddi 的括约肌松弛,从而促进胆汁排入十二指肠。Sincalide ammonium 可通过注射促进胆囊收缩,常用于辅助诊断胆囊、胰腺疾病和胆囊造影术。 | |||
TP2500 |
Cholecystokinin (26-33) free acid
CCK (26-33) free acid |
cholecystokinin | GPCR/G Protein |
Cholecystokinin (26-33) free acid 是胆囊收缩素 (CCK) 的一部分, 是脊椎动物中枢神经系统中存在的 CCKB 型受体的高选择性配体,可诱导大鼠轻度味觉厌恶条件反射。 | |||
TQ0062 |
Nastorazepide
Z-360 |
cholecystokinin | GPCR/G Protein |
Nastorazepide 是一种选择性的、口服有效的1,5-苯并二氮杂环衍生物胃泌素/胆囊收缩素2(CCK-2)受体拮抗剂,具有抗肿瘤的潜能。 | |||
TP1197 |
Sincalide
SQ19844,辛卡利特,CCK-8,Cholecystokinin octapeptide |
Others | Others |
Sincalide (CCK-8) 是一种速效的胆囊收缩素的氨基酸多肽激素类似物,可在胆囊造影术中静脉使用。它的肝胆生理作用是增加胆汁的分泌,使胆囊收缩并使 Oddi 的括约肌松弛,从而使胆汁排入十二指肠。它是一种通过注射促进胆囊收缩并帮助诊断胆囊和胰腺疾病的药物。 | |||
TP1931L1 |
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate(96736-12-8 free base) |
cholecystokinin | GPCR/G Protein |
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate ([D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate (96736-12-8 free base)) 是广谱神经肽反向激动剂和拮抗剂。 ghrelin 受体的强效完全反向激动剂(EC50 = 5.2 nM);减少组成型生长素释放肽受体信号传导。它也是速激肽、缓激肽、CCK 和铃蟾肽受体的拮抗剂。在体外诱导细胞凋亡并抑制癌细胞生长。 | |||
T16906 |
Sograzepide
YM-220,Netazepide,YF 476 |
Others | Others |
Sograzepide is an effective and highly selective Gastrin/CCK-B antagonist (IC50: 0.1 nM), has an inhibitory effect on Gastrin/CCK-A activity (IC50: 502 nM). Sograzepide replaces the specific binding of [125I]CCK-8 to the rat brain, cloned canine, and cloned human Gastrin/CCK-B receptors (Ki: 0.068, 0.62 and 0.19 nM, respectively). | |||
T10707 |
CCK-B Receptor Antagonist 2
|
Others | Others |
CCK-B Receptor Antagonist 2 is a potent and orally active antagonist of Gastrin/CCK-B (IC50: 0.43 nM). It also inhibits gastrin/CCK-A activity (IC50: 1.82 μM). | |||
T10055 |
(Iso)-FK-480
CHEMBL333994 |
cholecystokinin | GPCR/G Protein |
(Iso)-FK-480 是一种新型可口服的胆囊收缩素 A(CCK-A)拮抗剂,可用于研究治疗慢性胰腺炎。 | |||
T25921 |
Pbc 264
Pbc264,Pbc-264 |
||
Pbc 264 is a CCK agonist. | |||
T24287 |
L 365031
L 365,031,L365031,L-365,031,L-365031,L365,031 |
||
L 365031 is a CCK antagonist. | |||
T37205 |
CCK (26-31) (sulfated)
|
||
CCK (26-31) is an N-terminal fragment of CCK , a peptide hormone found in the intestine and brain that stimulates digestion, mediates satiety, and is involved in anxiety. The sulfated form of CCK (26-31) inhibits binding of [125I]CCK-33 to guinea pig cortical membranes by 21% when used at a concentration of 0.1 mM. | |||
T25139 |
BC 197
Boc-asp-tyr(SO3H)-ahx-lys-trp-ahx-asp-phe-NH2,BC197,BC-197 |
||
BC 197 is a selective CCK-B agonist. | |||
T26483 |
A-65186
A65186 |
||
A 65186 is a Type A Cholecystokinin (CCK) receptor antagonist. | |||
T37203 |
CCK (26-30) (sulfated)
|
||
CCK (26-30) is an N-terminal fragment of CCK , a peptide hormone found in the intestine and brain that stimulates digestion, mediates satiety, and is involved in anxiety. The sulfated form of CCK (26-30) inhibits binding of [125I]CCK-33 to guinea pig cortical membranes by 10% when used at a concentration of 0.1 mM. | |||
T13261 |
CCK-B Receptor Antagonist 1
|
Others | Others |
CCK-B Receptor Antagonist 1 is a cholecystokinin B (CCK-B) receptor agonist and has the potential of reducing the secretion of gastric acid. | |||
T26484 |
A71378
A-71378,A 71378 |
||
A71378 is a high potency, selectivity CCK-A receptors agonist. | |||
T25108 |
ARL 15849XX
ARL15849XX,FPL15849,FPL-15849,FPL 15849,ARL-15849XX |
||
ARL 15849XX, a CCK-8 analog, is a novel anti-obesity agent. | |||
T13084 | Tarazepide | Others | Others |
Tarazepide is a potent and specific antagonist of CCK-A receptor. | |||
T34669 |
Snf 8906
Snf-8906,Snf8906 |
||
Snf 8906 is a CCK-8 analog. | |||
T29502 |
A 70874
A-70874,A70874 |
||
A70874 has high selectivity and potency for cholecystokinin (CCK) a receptor. | |||
T27014 |
CI-1015
CI1015,CI 1015,PD 144598 |
||
CI-1015 is a CCK-B receptor antagonist with oral activity. | |||
T37204 |
CCK (26-31) (non-sulfated)
|
||
CCK (26-31) is an N-terminal fragment of CCK , a peptide hormone found in the intestine and brain that stimulates digestion, mediates satiety, and is involved in anxiety. | |||
T82732 |
Cholecystokinin (1-21)
CCK-1-21 |
||
Cholecystokinin (1-21),作为一种胆囊收缩素 (CCK) 片段,能够激活人体脂肪组织的脂肪分解作用。 | |||
T28342 |
PD-149164
PD 149164,PD149164 |
||
PD-149164 is an agonist of the CCK-A receptor. | |||
T23886 |
Cholecystokinin (27-32)-amide
Cholecystokinin (27-32)-NH2 |
||
Cholecystokinin (27-32)-amide is a CCK receptor antagonist. | |||
T32425 |
Ksg 504
Ksg504,Ksg-504 |
||
Ksg 504 has superior selectivity and affinity to CCK-A receptors and derived from proglumide. | |||
T27900 |
LY 219057
LY-219057,LY219057 |
||
LY 219057 is a potent, competitive, and specific antagonist of CCK receptor on the exocrine pancreas. | |||
T15101 |
Devazepide
L-364,718,地伐西匹,MK-329 |
Others | Others |
Devazepide is a competitive and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor (IC50s: 81 pM, 45 pM, and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively). | |||
T23946 |
DA-3934
UNII-J353803KRG |
||
DA-3934 has a high affinity for gastrin/CCK-B receptors and high selectivity over CCK-A receptors. DA-3934 and its methyl ester derivative inhibited pentagastrin-induced gastric acid secretion in rats in a dose-dependent manner. | |||
T32297 |
Jmv 180
Cck-jmv-180,Jmv-180,Jmv180 |
||
Jmv 180, a CCK analog, can distinguish high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors. | |||
T25437 |
Fpl 14294
Fpl-14294,Fpl14294 |
||
Fpl 14294 is a novel CCK-8 agonist with effective intranasal anorectic activity in the rat. | |||
T37206 |
CCK (27-33) (non-sulfated)
|
||
CCK (27-33) is a C-terminal fragment of CCK , a peptide hormone found in the intestine and brain that stimulates digestion, mediates satiety, and is involved in anxiety. Non-sulfated CCK (27-33) inhibits binding of [3H]naloxone in rat cerebellum membranes (IC50 = 4 uM) and inhibits electrically-stimulated contraction of isolated guinea pig ileum (IC50 = 17 uM), an effect that can be reversed by naloxone. Unlike sulfated CCK (27-33), the non-sulfated form does not reduce exploratory behavior in m... | |||
T39170 |
Cholecystokinin Octapeptide, desulfated TFA
CCK Octapeptide, desulfated TFA,Cholecystokinin Octapeptide, desulfated TFA |
||
Cholecystokinin Octapeptide, desulfated TFA, is a synthetic octapeptide derived from Cholecystokinin (CCK) that has undergone desulfation. | |||
T62039 | L-365260 hemihydrate | ||
L-365260 hemihydrate 是选择性的、具有口服活性的非肽胃泌素和脑胆囊收缩素受体 (CCK-B) 拮抗剂,Kis 值分别为 1.9 nM 和 2.0 nM。L-365260 hemihydrate 以竞争性方式与豚鼠胃泌素和脑 CCK 受体相互作用。 | |||
T25553 |
Jmv 332
Jmv-332,Jmv332 |
||
Jmv 332 is a cyclic analog of the C-terminal hexapeptide of CCK. It is a CCK/gastrin receptor agonist. | |||
T27774 |
L-740093
L 740093 |
||
L-740093 is a specific antagonist of CCK-B receptor. | |||
T17274 |
YM022
|
CCR | Immunology/Inflammation; Microbiology/Virology |
YM022 is a highly effective and selective gastrin/cholecystokinin (CCK)-B receptor antagonist. YM022 can inhibit gastrin-induced gastric acid secretion and histidine decarboxylase activation in vivo. YM022 shows the Ki values of 68 pM and 63 nM for CCK-B and CCK-A receptor, respectively. | |||
T28331 |
PD 136450
Cam1189,PD136450,Cam-1189,PD-136450,Cam 1189 |
||
Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat. Gastrin (cholecystokinin type B (CCK-B)) receptor antagonists may help to elucidate the physiological role o | |||
T15105 | Dexloxiglumide | Others | Others |
Dexloxiglumide, an active enantiomer of Loxiglumide, inhibits smooth muscle cell contractions induced by cholecystokinin-octapeptide (CCK-8). It is a selective antagonist of cholecystokinin type A (CCKA) receptors. | |||
T26482 |
A-57696
|
||
A-57696 is a cholecystokinin antagonist with selective for cortical CCK-B receptors (IC50 = 25 nM). | |||
T25550 |
Jmv 176
Jmv-176,Jmv176,Boc-tyr(SO3)-nle-psi-(coch2)-gly-trp-nle-asp-phe-NH2 |
||
Jmv 176 is a CCK agonist when first given and becomes a cholecystokinin antagonist after 3-4 hours. | |||
T27772 |
L-736380
L-736,380,L 736380,L736,380,L 736,380 |
||
L-736380 is a CCK-B receptor antagonist. L-736,380 dose-dependently inhibited gastric acid secretion in anesthetized rats (ID(50), 0.064 mg/kg) and ex vivo binding of [(125)I]CCK-8S in BKTO mice brain membranes (ED(50), 1.7 mg/kg). | |||
T12544 | Proglumide hemicalcium | Others | Others |
Proglumide hemicalcium is a antagonist of nonpeptide and orally active cholecystokinin (CCK)-A/B receptors, has antiepileptic and antioxidant activities. |